• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,250.80 5.16
(0.01%)
Dow Jones
7,521.33 -8.87
(-0.12%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Asston Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
544445
INE0SJX01015
45.6540372
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
14.31
55.32
EPS(TTM)
Face Value()
Div & Yield %
4.54
10
0
 

Mastek consolidated net profit rises 30.94% in the March 2026 quarter
Apr 17,2026
Net profit of Mastek rose 30.94% to Rs 106.15 crore in the quarter ended March 2026 as against Rs 81.07 crore during the previous quarter ended March 2025. Sales rose 3.60% to Rs 938.00 crore in the quarter ended March 2026 as against Rs 905.42 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.47% to Rs 404.00 crore in the year ended March 2026 as against Rs 375.93 crore during the previous year ended March 2025. Sales rose 7.05% to Rs 3698.75 crore in the year ended March 2026 as against Rs 3455.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales938.00905.42 4 3698.753455.23 7
OPM %16.0715.32 -15.8315.82 -
PBDT167.43132.71 26 623.95526.67 18
PBT148.96114.05 31 551.34451.55 22
NP106.1581.07 31 404.00375.93 7